Trial Profile
The evaluation of atorvastatin on wall shear stress, atherosclerosis composition, and microvascular function in patients with moderate coronary disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jun 2015
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Pharmacodynamics
- 13 Sep 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 11 Jan 2008 New trial record.